Crosstalk Between Oxidative Stress and Endoplasmic Reticulum (ER) Stress in Endothelial Dysfunction and Aberrant Angiogenesis Associated With Diabetes: A Focus on the Protective Roles of Heme Oxygenase (HO)-1

Frontiers in Physiology
Hatem MaamounAbdelali Agouni

Abstract

Type-2 diabetes prevalence is continuing to rise worldwide due to physical inactivity and obesity epidemic. Diabetes and fluctuations of blood sugar are related to multiple micro- and macrovascular complications, that are attributed to oxidative stress, endoplasmic reticulum (ER) activation and inflammatory processes, which lead to endothelial dysfunction characterized, among other features, by reduced availability of nitric oxide (NO) and aberrant angiogenic capacity. Several enzymatic anti-oxidant and anti-inflammatory agents have been found to play protective roles against oxidative stress and its downstream signaling pathways. Of particular interest, heme oxygenase (HO) isoforms, specifically HO-1, have attracted much attention as major cytoprotective players in conditions associated with inflammation and oxidative stress. HO operates as a key rate-limiting enzyme in the process of degradation of the iron-containing molecule, heme, yielding the following byproducts: carbon monoxide (CO), iron, and biliverdin. Because HO-1 induction was linked to pro-oxidant states, it has been regarded as a marker of oxidative stress; however, accumulating evidence has established multiple cytoprotective roles of the enzyme in metabolic and...Continue Reading

References

Oct 1, 1987·The Journal of Diabetic Complications·R Osterby, G Nyberg
Jan 1, 1997·Proceedings of the Society for Experimental Biology and Medicine·A I GoodmanN G Abraham
Apr 1, 1997·Cardiovascular Research·G M PieperW Siebeneich
Jul 15, 1997·European Journal of Biochemistry·W K McCoubreyM D Maines
Oct 6, 1997·Proceedings of the National Academy of Sciences of the United States of America·K D Poss, S Tonegawa
Oct 6, 1997·Proceedings of the National Academy of Sciences of the United States of America·K D Poss, S Tonegawa
Jan 12, 1999·The Journal of Clinical Investigation·A YachieS Koizumi
Jan 23, 1999·The Journal of Clinical Investigation·M IgarashiG L King
Oct 4, 2000·The Journal of Experimental Medicine·S BrouardM P Soares
Nov 15, 2000·American Journal of Physiology. Lung Cellular and Molecular Physiology·V J Thannickal, B L Fanburg
Jun 1, 2001·Nature Medicine·H J DuckersE G Nabel
Mar 5, 2002·Nature Medicine·Tzong-Shyuan Lee, Lee-Young Chau
Jul 18, 2002·Journal of Inorganic Biochemistry·Robert R CrichtonRoberta J Ward
Apr 22, 2003·Journal of Cellular Physiology·William Durante
Apr 24, 2003·Experimental Biology and Medicine·Yen-Hsu ChenMark A Perrella
Jun 14, 2003·Proceedings of the National Academy of Sciences of the United States of America·Radia TamaratBernard I Lévy
Jul 15, 2003·The Journal of Biological Chemistry·Danielle MorseAugustine M K Choi
Aug 2, 2003·Journal of Cellular Physiology·Carine Michiels
Oct 22, 2003·Circulation·Kathy K Griendling, Garret A FitzGerald
Oct 29, 2003·Circulation·Kathy K Griendling, Garret A FitzGerald
Feb 6, 2004·The Journal of Cell Biology·Benjamin P Tu, Jonathan S Weissman
Jul 16, 2004·The Journal of Biological Chemistry·Seema Chakravarthi, Neil J Bulleid
Aug 28, 2004·The American Journal of Pathology·Matthias H KapturczakAnupam Agarwal
Sep 16, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Weizheng W WangStephen D Zucker
Oct 16, 2004·Science·Umut OzcanGökhan S Hotamisligil
Oct 23, 2004·Arteriosclerosis, Thrombosis, and Vascular Biology·Keiichi KawamuraYukio Maruyama

❮ Previous
Next ❯

Citations

Jul 25, 2019·Antioxidants·Peter F SuraiMichael T Kidd
Nov 27, 2019·Toxins·Marie FrimatLubka T Roumenina
Jan 29, 2020·Neurochemical Research·Rita de Cássia Noronha MedeirosFabiano Mendes de Cordova
May 28, 2020·International Journal of Molecular Sciences·Undral BuyandelgerIkuo Tooyama
May 8, 2020·Oxidative Medicine and Cellular Longevity·Elena FrigatoGiuseppe Valacchi
Sep 4, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Pattawika LertpatipanpongSeung Joon Baek
Mar 20, 2020·Cellular & Molecular Biology Letters·Sylwia Bartoszewska, James F Collawn
May 14, 2020·F1000Research·Michael D BriggsKatarzyna A Pirog
May 7, 2020·Frontiers in Neuroscience·Xiaohua Song, Dingxin Long
Jun 23, 2019·International Journal of Molecular Sciences·Jessica MaiuoloVincenzo Mollace
Jun 18, 2020·Biomolecules·Adrianna MoszyńskaRafal Bartoszewski
Nov 27, 2020·Journal of Cellular Physiology·Matshediso ZachariahAbdelali Agouni
Oct 31, 2020·Oxidative Medicine and Cellular Longevity·Amira Mohammed Ali, Hiroshi Kunugi
Feb 20, 2021·BMC Complementary Medicine and Therapies·Chatchai NensatArunya Jiraviriyakul
May 20, 2020·International Journal of Biological Macromolecules·Yingshu ZhaoBaojun Xu
Apr 1, 2021·Free Radical Research·Karan Naresh AminKunka Mohanram Ramkumar
Mar 28, 2021·Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)·Wui Fang Chai, Kim San Tang
Apr 24, 2021·World Journal of Diabetes·Jake RajbhandariJoseph M Pappachan
Apr 27, 2021·Oxidative Medicine and Cellular Longevity·Karan Naresh AminRamkumar Kunka Mohanram
Nov 14, 2020·International Journal of Molecular Sciences·Ga-Eun LimYong-Nyun Kim
Jul 25, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Sagir MustaphaSiti Safiah Mokhtar
Jul 30, 2021·Frontiers in Cell and Developmental Biology·Namita ChatterjeeSudarshan Anand

❮ Previous
Next ❯

Methods Mentioned

BETA
glycation
protein folding
nuclear translocation

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.